- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Health Catalyst Inc(HCAT)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HCAT
11/13/2026: HCAT (1-star) is currently NOT-A-BUY. Pass it for now.
Health Catalyst Inc is a small-cap healthcare technology company providing data analytics platforms and professional services to hospitals and health systems. The company's primary strength lies in its specialized healthcare data architecture and high-margin recurring software revenues, though overall growth has slowed. Its core investment opportunity centers on a strategic pivot toward AI-driven automation and software margin expansion. Key risks include intense competition from dominant electronic health record vendors, customer churn during platform migrations, and persistent GAAP net losses. The stock suits patient value-oriented investors willing to monitor execution on cash generation and platform transition milestones.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Top-line revenue growth has decelerated to low single digits, muting immediate appeal for aggressive growth seekers. |
| Momentum investor | Weak fit | The stock has experienced multi-year downward pressure, offering low momentum appeal absent a strong fundamental breakout. |
| Value investor | Strong fit while signal remains positive | The company trades at depressed valuation multiples relative to its net cash cushion and recurring software revenue base. |
| Dividend investor | Weak fit | Health Catalyst does not pay dividends, rendering it unsuitable for income-focused portfolios. |
| Low-risk investor | Weak fit | High share price volatility and ongoing GAAP profitability challenges expose risk-averse investors to significant equity drawdowns. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock exhibits high beta and sharp price swings characteristic of small-cap technology equities. |
| Valuation risk | Medium | Although discounted on an enterprise value basis, market sentiment remains fragile pending sustained profitability. |
| Competition risk (EHR bundling & AI competition) | High | Intense competitive pressure from dominant EHR vendors bundling analytics creates ongoing pricing and churn hurdles. |
| Business quality | Medium / high | High recurring technology gross margins indicate strong underlying software quality, offset by GAAP operating losses. |
| Dividend income | Low / none | No dividend is paid, offering zero income return for shareholders. |
| Execution risk | High | Successfully executing the transition toward high-margin software while navigating product migrations is critical to turnaround success. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 114.99M USD | Price to earnings Ratio - | 1Y Target Price 1.77 |
Price to earnings Ratio - | 1Y Target Price 1.77 | ||
Volume (30-day avg) 403.1K shares | Beta 1.51 | 52 Weeks Range 0.96 - 3.02 | Updated Date 11/15/2026 |
52 Weeks Range 0.96 - 3.02 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.8 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Health Information Services
- BUY participation
- 100.0%
- Active BUY / eligible
- 4 / 4
- 30-Day BUY Count Change
- +2
Eligible universe: 4 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -59.65% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Technology Segment (Cloud Software) | Cloud-based data platform subscriptions, time-based licenses, and maintenance support fees for analytics applications. | This is the core software engine driving recurring revenue and higher gross margins. |
| Professional Services Segment | Implementation, strategic advisory, custom analytics development, and outcome improvement consulting. | These services help hospital clients deploy and utilize software, though management is intentionally streamlining this segment to favor profitability. |
| Geographic Exposure | Concentrated primarily within the United States healthcare provider and hospital market. | Revenues depend heavily on U.S. hospital IT budgets and regulatory healthcare structures. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 10 | Enterprise Value 51.76M | Price to Sales(TTM) 0.42 |
Enterprise Value 51.76M | Price to Sales(TTM) 0.42 | ||
Enterprise Value to Revenue 0.19 | Enterprise Value to EBITDA -4.96 | Shares Outstanding 76.16M | Shares Floating 60.17M |
Shares Outstanding 76.16M | Shares Floating 60.17M | ||
Percent Insiders 9.46 | Percent Institutions 69.69 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

